March 04, 2026

GROWell App Fails to Curb Pregnancy Weight Gain

Mobile health intervention does not significantly reduce excessive gestational weight gain or postpartum weight retention in randomized trial

Conexiant

February 27, 2026

Can Testosterone Affect Cognitive Function? 

Systematic review finds modest, population-dependent effects on mood and cognition in adult men 

Conexiant

February 25, 2026

AI May Help Close Women's Health Gap

Endometriosis was cited to illustrate challenges, with definitive diagnosis estimated to take an average of 7 to 10 years.

Conexiant

February 24, 2026

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

Retrospective study finds machine-learning model identifies clinical factors associated with preterm delivery in a high-risk obstetric population.

Conexiant

February 23, 2026

Lifestyle Interventions vs Gestational Diabetes

Investigators report that lifestyle interventions during pregnancy reduce gestational diabetes risk, with effects varying by diagnostic criteria and maternal education level.

Conexiant

February 18, 2026

Manual IVF Screening May Miss Additional Oocytes

Clinical study suggests automated system can recover mature oocytes overlooked during standard screening

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

November 18, 2024

Leptin's Role in Energy Deficiency Syndromes

Researchers present new insights into Relative Energy Deficiency in Sport, emphasizing its impact on athletes and military personnel, and discussing potential prevention and treatment strategies.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant